Immune-related adverse events with resumed anti-PD-1 therapy

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2017年 / 1676卷 / 1期
关键词：
D O I：
10.1007/s40278-017-37992-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [1] Anti-PD-1 antibodies: immune-related adverse events and efficacy
    [J]. Reactions Weekly, 2019, 1739 (1) : 6 - 6
  • [2] Immune-related adverse event recurrence with anti-PD-1 therapy
    [J]. Reactions Weekly, 2020, 1816 (1) : 8 - 8
  • [3] Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab
    Eun, Yeonghee
    Kim, In Young
    Sun, Jong-Mu
    Lee, Jeeyun
    Cha, Hoon-Suk
    Koh, Eun-Mi
    Kim, Hyungjin
    Lee, Jaejoon
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [4] Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab
    Yeonghee Eun
    In Young Kim
    Jong-Mu Sun
    Jeeyun Lee
    Hoon-Suk Cha
    Eun-Mi Koh
    Hyungjin Kim
    Jaejoon Lee
    [J]. Scientific Reports, 9
  • [5] Association Between Immune-Related Adverse Events During Anti-PD-1 Therapy and Tumor Mutational Burden
    Bomze, David
    Ali, Omar Hasan
    Bate, Andrew
    Flatz, Lukas
    [J]. JAMA ONCOLOGY, 2019, 5 (11) : 1633 - 1635
  • [6] Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience
    Sebestyen, Eniko
    Major, Nora
    Bodoki, Levente
    Makai, Attila
    Balogh, Ingrid
    Toth, Gabor
    Orosz, Zsuzsanna
    Arkosy, Peter
    Vasko, Attila
    Hodosi, Katalin
    Szekanecz, Zoltan
    Szekanecz, Eva
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] Prognostic significance of immune-related adverse events and immunosuppression in patients with melanoma receiving adjuvant anti-PD-1 therapy
    Knight, Andrew David
    Karapetyan, Lilit
    Bruno, Sabrina
    Abushukair, Hassan Mohammed
    Bo, Na
    Wang, Hong
    Sander, Cindy
    Kirkwood, John M. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Immune-related adverse events in a patient with eosinophilic enteritis treated with immune checkpoint inhibitors (anti-PD-1)
    Cybulska-Stopa, Bozena
    Kaminska-Winciorek, Grazyna
    Dyduch, Grzegorz
    [J]. MELANOMA RESEARCH, 2020, 30 (06) : 619 - 624
  • [9] Cutaneous immune-related adverse events in 1,857 patients treated with anti-PD-1 therapy at an academic center
    Le, T.
    Kaul, S.
    Cappelli, L.
    Naidoo, J.
    Kwatra, S. G.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S108 - S108
  • [10] Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients
    Rogado, J.
    Sanchez-Torres, J. M.
    Romero-Laorden, N.
    Ballesteros, A., I
    Pacheco-Barcia, V
    Ramos-Levi, A.
    Arranz, R.
    Lorenzo, A.
    Gullon, P.
    Donnay, O.
    Adrados, M.
    Costas, P.
    Aspa, J.
    Alfranca, A.
    Mondejar, R.
    Colomer, R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 109 : 21 - 27
12345